World of DTC Marketing
AUGUST 30, 2022
Digital ad spending in the industry will reach $15.84 billion in 2022. Although growth in digital budgets is slowing, we estimate the category will see nearly $20 billion in spending in 2024. For every $1 million invested in online banner ads, just 0.1%, or $1,000, derives value for brands, resulting in $999,000 wasted by brands. So why is pharma wasting so much money?
MedCity News
AUGUST 30, 2022
Neurocrine Biosciences is acquiring Diurnal Group, a U.K-based biotech that has commercialized two endocrine disorder drugs. Neurocrine’s top-selling product is a blockbuster drug for an involuntary muscle movement disorder.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
AUGUST 30, 2022
The Community Alliance Network is the latest industry initiative looking to the pharmacy counter to help improve trial recruitment diversity.
MedCity News
AUGUST 30, 2022
Amgen said its drug Lumakras met the main goal of a Phase 3 study in non-small cell lung cancer driven by a particular genetic mutation. The pharmaceutical giant offered no specifics, but the results set the stage for an interesting regulatory race with a rival drug from Mirati Therapeutics.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
European Pharmaceutical Review
AUGUST 30, 2022
Researchers from UPV/EHU-University of the Basque Country, Spain, have successfully produced different types of starch-based pharmaceutical tablets using 3D printing. The aim of the study, published in the International Journal of Pharmaceutics , was to produce 3D printed starch-based tablets for the tailored delivery of hydrophobic drugs. Hydrophobic drugs – those that poorly water soluble – account for some 40% of marketed drugs and the 60% of the drug candidates in research, the paper notes.
MedCity News
AUGUST 30, 2022
Avenda Health, an AI company focused on personalized prostate cancer care, recently closed a $10 million Series B funding round. The company’s platform seeks to personalize treatment to the patient and their specific case to preserve quality of life and prevent cancer recurrence.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 30, 2022
Health data company CuriMeta launched on Tuesday and announced the close of a $6 million seed funding round led by its two institutional partners, BJC HealthCare and the Washington University School of Medicine. The company’s mission is to leverage its two institutional partners’ deep data resources to create more useful data that enables quicker discoveries of new diagnostics and medical interventions.
PharmaVoice
AUGUST 30, 2022
The biotech says that its competitors’ COVID-19 vaccine copied proprietary mRNA technology. Here’s a breakdown of the case.
MedCity News
AUGUST 30, 2022
The four companies are Alma, Headway, NOCD and Ophelia. Alma and Headway will help Empire expand its mental health provider network, while NOCD and Ophelia will address specific conditions: obsessive-compulsive disorder and opioid use disorder, respectively.
pharmaphorum
AUGUST 30, 2022
Neurocrine Biosciences has featured on lists of potential takeover candidates for years, but has now taken the lead on a buyout of UK biotech Diurnal that if consummated will extend its therapeutic focus further into hormonal disorders. The 27.5 pence-a-share cash deal values Diurnal at around £48.3 million ($57 million), a 144% premium to the biotech’s closing share price on Friday.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
AUGUST 30, 2022
Decreased spending power compounds the impact of social risk particularly by surfacing other associated deficiencies in areas such as health literacy, digital access and social isolation.
pharmaphorum
AUGUST 30, 2022
Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial programme will investigate the potential of asundexian in up to 30,000 patients with atrial fibrillation (AF) as well as patients with a non-cardioembolic ischaemic stroke or high-risk transient ischemic attack (TIA), said Bayer.
MedCity News
AUGUST 30, 2022
In a recent interview, Jennifer Cubino, COO of BC Platforms, discussed regulatory differences between the U.S., the European Union and other countries amid ongoing efforts to encourage patients who want to share their data.
Map My Customers
AUGUST 30, 2022
You’ve done your sales prospecting, initiated a relationship, scheduled a meeting, and performed a demo. Now comes the part that many sales reps dread. Closing the deal. However, closing a deal is arguably the most important part of the sales process. It’s what turns casual observers and interested parties into real, paying customers. The close is also the part that helps you earn commission and hit your sales quotas.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
MedCity News
AUGUST 30, 2022
In the near future, healthcare organizations will likely need to document how they collect health equity data, screen patients for social determinants of health, and address disparities in care.
European Pharmaceutical Review
AUGUST 30, 2022
Diversity within the pharmaceutical sector and clinical trials continues to be a problem, according to a recent report by data and analytics company GlobalData. The report, Clinical Trials – The Importance of Diversity in Clinical Trials , examined data from clinical trials initiated between 1 January 2013 and 16 June 2022. Disclosed racial representation data was analysed by location, year, trial phase, therapy area, among other factors.
pharmaphorum
AUGUST 30, 2022
New practical guide walks digital health entrepreneurs through the patient and public involvement and engagement process. . Digital transformation could revolutionise healthcare, making for happier, healthier populations – but only if solutions are designed and deployed with patients at the heart. . That’s why a newly published, evidence-based guide for digital innovators, from the Academic Health Science Networks (AHSN) Network, the University of Plymouth, and Boehringer Ingelheim, aims to s
MedReps
AUGUST 30, 2022
Did you know most people set goals yet never achieve them? Think for a minute about your New Years’ Resolutions. How many of them have you followed through with over the years? If you answered “none,” then you certainly aren’t alone. The same goes for your goals as a medical sales rep. If you never focus on your goals, you’ll never reach them. Since these goals are work-related, there’s a bit more riding on them than on your New Years’ Resolutions.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
ALULA
AUGUST 30, 2022
Video discussion with John Dale , Global Energy Practice Lead and Alycia Diggs-Chavis, Executive and Team Coach.
PharmaTimes
AUGUST 30, 2022
Therapy is a biosimilar of Lucentis which treats several serious retinal diseases across the European Union
pharmaphorum
AUGUST 30, 2022
AstraZeneca’s Farxiga reduced the risk of hospitalisation and death in people with all types of heart failure in the DELIVER trial, which could dramatically increase the population of patients eligible for treatment with the SGLT2 inhibitor. The study showed that treatment with Farxiga (dapagliflozin) reduced led to an 18% reduction in cardiovascular death or worsening heart failure in patients with both mildly reduced and preserved ejection fraction, said AZ.
PharmaTimes
AUGUST 30, 2022
It is estimated that every year more than 6,300 people will be diagnosed with CML in Europe
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scott’s Directories
AUGUST 30, 2022
Today, all businesses rely on digital marketing to connect with their customers, and the healthcare industry is no exception. With the changes in society and the needs of consumers, B2B healthcare companies also need to rely on marketing strategies such as social media, PPC, and medical databases to increase their sales. However, marketing is relatively new to the industry.
Evolve Your Success
AUGUST 30, 2022
There are a lot of misconceptions about what it means to work in medical sales, whether in pharmaceutical sales, medical device sales, or diagnostic testing. And that happens most especially in a role like trauma. In this episode, Julia Greenspan debunks the myth of medical device reps in trauma sales and levels the playing field in orthopedic trauma.
Pharmaceutical Technology
AUGUST 30, 2022
The US Food and Drug Administration (FDA) has accepted Sanofi ’s efanesoctocog alfa (BIVV001) Biologics License Application (BLA), to treat haemophilia A, for priority review. A decision from the regulatory agency on approval for the therapy is anticipated on 28 February next year. The application is based on findings from the open-label, non-randomised, interventional Phase III XTEND-1 clinical trial designed to evaluate the safety, efficacy and pharmacokinetics of efanesoctocog alfa given once
Impetus Digital
AUGUST 30, 2022
Register for Impetus’ upcoming live webinar on September 14, 10-11 AM ET: A Fireside Chat with Dr. Waqaas Al-Siddiq, Founder & CEO of Biotricity. About the webinar. Dr. Waqaas Al-Siddiq Founder & CEO of Biotricity , will sit down with Natalie Yeadon , Co-founder & CEO of Impetus Digital , to discuss his journey from computer engineering to healthcare, innovation in the cardiac monitoring space, the concept of Mobile Cardiac Telemetry (MCT), and more.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Quantified
AUGUST 30, 2022
Without a successful sales team , an organization can’t thrive. The sales team turns leads into customers, guiding prospects through their concerns until they arrive at the sale. But while an effective sales team is crucial to your bottom line, a sales team can’t function correctly without hiring a sales manager to lead it. . That leads to another question: how do you identify and hire the best sales manager for your organization?
Scott Burrows
AUGUST 30, 2022
As someone who started his career as a financial sales advisor and then later a sales motivational speaker, I am keenly interested in how sales teams involve themselves in the management of resilience. In an insightful article for Forbes magazine (February 10, 2022), business writer Brian Zawada reviews five key areas of resilience.
Pharmaceutical Technology
AUGUST 30, 2022
RANKINGS 2022 Excellence Business Expansion Commended Excellence Innovation Commended Excellence Investments Commended. The Verdict. Verista is a Life Sciences business, technology and compliance firm specializing in systems, quality, and validation solutions throughout the product lifecycle. The company has been ranked in the 2022 Excellence Rankings in the areas of Business Expansion , Innovation and Investments.
PharmExec
AUGUST 30, 2022
Hogan Lovells released a survey that tracked the thinking of compliance professionals who are implementing ESG into compliance programs.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
270 
Let's personalize your content